No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong Edward Berger?

Dr. Edward A. Berger


National Institutes of Health

Direct Phone: (301) ***-****       

Email: e***@***.gov

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

National Institutes of Health

31 Center Dr. MSC 2062 Building 31, Room B1-W30

Bethesda, Maryland 20892

United States

Company Description

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supportin ... more

Find other employees at this company (26,023)

Background Information

Employment History


National Institute of Allergy and Infectious Diseases

Staff Scientist With the Cell Biology Group

Worcester Foundation for Experimental Biology


Scientific Advisory Board Member
Institute of Human Virology

Board of Advisors Member
Institute of Human Virology




City College of the City University of New York



biochemistry and molecular biology

Cornell University

Web References (53 Total References)

Edward Berger, ... [cached]

Edward Berger, Ph.D. NIAID/NIH

Edward A. Berger.
Dr. Berger earned his B.S. in chemistry from City College of the City University of New York in 1968. He received his Ph.D. in biochemistry and molecular biology in 1973 from Cornell University. He went on to do a postdoctoral fellowship in the department of genetics, biochemistry, and neurobiology at Stanford University School of Medicine from 1973 to 1976 and another fellowship in the department of cellular and developmental immunology at Scripps Clinical and Research Foundation from 1976 to 1977. He was a staff scientist with the Cell Biology Group at the Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts, from 1977 to 1987.

Edward Berger, a virologist ... [cached]

Edward Berger, a virologist at the National Institutes of Health who helped discover how HIV enters human cells, thinks it may be possible to permanently keep the virus in check, a so-called "functional cure. In February, he says, he will start giving monkeys T cells genetically programmed to find and destroy any cell in which the simian version of HIV is replicating.

The actual process isn't as simple as the theory. Berger is sure that years of missteps and do-overs lie ahead. Also, most protocols involving engineered T cells require patients, or monkeys, to take drugs that temporarily kill off their own T cells, which isn't without risks. "Where the technology stands, it's a pretty radical treatment," Berger says. "You aren't going to use it on a cold sore. But despite all the progress that has been made treating HIV, a better approach is still needed. Because the virus hides in the body even after treatment, patients have to take antiretroviral drugs for life. With immune engineering, maybe not. Berger sees the chance of a one-time treatment that can hold the virus in check for good.
"I was totally inspired by the cancer work," he says.

GAJ - HIV DART 2008 Presentations [cached]

Edward Berger, National Institutes of Health, USA

Development of Pyrimidinedione NNRTIs with a High Genetic Barrier to Resistance

Advisory Boards: Institute of Human Virology [cached]

Edward Berger, Ph.D. NIAID/NIH

Rediscovering Biology - Expert Interview Transcripts [cached]

Edward A. Berger, PhD

Berger is chief of the Molecular Structure Section in the laboratory of viral diseases in NIAID and NIH.Berger's lab identified the first HIV co-receptor, a molecule that Dr. Berger and his colleagues dubbed "fusin."They showed that fusin must be present on the surface of CD4+ T cells in order for HIV to enter and infect these cells.Soon thereafter, Berger's group and others showed that other HIV strains use different co-receptors to gain entry into target cells.

Similar Profiles

Other People with this Name

Other people with the name Berger

Edo Berger
Harvard University

Laura Berger
Commodity Search Partners Ltd

Matthew Berger
Wolfson Verrichia Group Inc.

Kelsey Berger
Competitive Energy Services LLC

Jeremy Berger
Level 3 Communications , Inc.

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory